U.S. Atopic Dermatitis Drugs Market Size & Outlook

Name: U.S. Atopic Dermatitis Drugs Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The atopic dermatitis drugs market in the United States is expected to reach a projected revenue of US$ 11,943.9 million by 2033. A compound annual growth rate of 6.8% is expected of the United States atopic dermatitis drugs market from 2026 to 2033.

U.S. atopic dermatitis drugs drug class outlook (Revenue, USD million, 2021-2033)
- Corticosteroids
- Calcineurin Inhibitors
- PDE4 Inhibitors
- Biologics
- Others
U.S. atopic dermatitis drugs route of administration outlook (Revenue, USD million, 2021-2033)
- Topical
- Parenteral
- Oral
U.S. atopic dermatitis drugs distribution channel outlook (Revenue, USD million, 2021-2033)
- Hospital Pharmacies
- Retail Pharmacies
- Others

U.S. Atopic Dermatitis Drugs Market Size & Outlook

Sign up - it's easy, and free!